Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan
Authors
Keywords
Hepatitis B virus, Entecavir, HBsAg seroclearance, Resistance, Viral breakthrough
Journal
JOURNAL OF GASTROENTEROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-22
DOI
10.1007/s00535-018-1502-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
- (2018) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
- (2017) George V. Papatheodoridis et al. HEPATOLOGY
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs)
- (2017) Glenda Grossi et al. LIVER INTERNATIONAL
- Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response
- (2017) Ju-Yeon Cho et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels
- (2017) Yuk-Fai Lam et al. Clinical and Translational Gastroenterology
- Review article: the potential of interferon and nucleos(t)ide analogue combination therapy in chronic hepatitis B infection
- (2016) M. Viganò et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs
- (2016) Fumitaka Suzuki et al. JOURNAL OF GASTROENTEROLOGY
- Sequential therapy with entecavir and pegylated interferon in a cohort of young patients affected by chronic hepatitis B
- (2016) Lucio Boglione et al. JOURNAL OF MEDICAL VIROLOGY
- AASLD guidelines for treatment of chronic hepatitis B
- (2015) Norah A. Terrault et al. HEPATOLOGY
- Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study)
- (2015) Willem Pieter Brouwer et al. HEPATOLOGY
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Characterization of novel entecavir resistance mutations
- (2015) Sanae Hayashi et al. JOURNAL OF HEPATOLOGY
- Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
- (2014) Pauline Arends et al. GUT
- Efficacy of Entecavir Treatment for up to 5 Years in Nucleos(t)ide-Naïve Chronic Hepatitis B Patients in Real Life
- (2013) Jie Luo et al. International Journal of Medical Sciences
- Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up
- (2013) Mariko Kobayashi et al. JOURNAL OF GASTROENTEROLOGY
- Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment
- (2013) Wai-Kay Seto et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- 755 5-YEAR ENTECAVIR TREATMENT IN NUC-NAÏVE, FIELD-PRACTICE PATIENTS WITH CHRONIC HEPATITIS B SHOWED EXCELLENT VIRAL SUPPRESSION AND SAFETY PROFILE BUT NO PREVENTION OF HCC IN CIRRHOTICS
- (2013) P. Lampertico et al. JOURNAL OF HEPATOLOGY
- Long-term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide-naïve chronic hepatitis B patients
- (2013) T. Hara et al. JOURNAL OF VIRAL HEPATITIS
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
- (2012) Tetsuya Hosaka et al. HEPATOLOGY
- Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan
- (2012) Fumitaka Suzuki et al. JOURNAL OF GASTROENTEROLOGY
- Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study
- (2012) Tetsuya Hosaka et al. JOURNAL OF GASTROENTEROLOGY
- Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients
- (2012) Atsushi Ono et al. JOURNAL OF HEPATOLOGY
- Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection
- (2010) Osamu Yokosuka et al. JOURNAL OF HEPATOLOGY
- Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial
- (2009) Michiko Shindo et al. Hepatology International
- Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: Phase II clinical study in Japan
- (2009) Haruhiko Kobashi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started